A research team of Banaras Hindu University (BHU) has first time reported the in vitro and in vivo therapeutic efficacy of nimbolide(a bioactive component of neem plant) against T cell lymphoma, which is a cancer of immune cells, and strongly advocated the utility of nimbolide as a
